These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

205 related articles for article (PubMed ID: 22391075)

  • 1. Aspirin-sensitive asthma and upper airway diseases.
    Chang JE; Chin W; Simon R
    Am J Rhinol Allergy; 2012; 26(1):27-30. PubMed ID: 22391075
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Intranasal ketorolac, diagnosis, and desensitization for aspirin-exacerbated respiratory disease.
    Nguyen A; Zuraw BL; Wu C; Kim A; Christiansen SC
    Ann Allergy Asthma Immunol; 2021 Jun; 126(6):674-680. PubMed ID: 33476718
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Use of intranasal ketorolac and modified oral aspirin challenge for desensitization of aspirin-exacerbated respiratory disease.
    Lee RU; White AA; Ding D; Dursun AB; Woessner KM; Simon RA; Stevenson DD
    Ann Allergy Asthma Immunol; 2010 Aug; 105(2):130-5. PubMed ID: 20674823
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The role of aspirin desensitization followed by oral aspirin therapy in managing patients with aspirin-exacerbated respiratory disease: A Work Group Report from the Rhinitis, Rhinosinusitis and Ocular Allergy Committee of the American Academy of Allergy, Asthma & Immunology.
    Stevens WW; Jerschow E; Baptist AP; Borish L; Bosso JV; Buchheit KM; Cahill KN; Campo P; Cho SH; Keswani A; Levy JM; Nanda A; Laidlaw TM; White AA
    J Allergy Clin Immunol; 2021 Mar; 147(3):827-844. PubMed ID: 33307116
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Long-term Clinical Outcomes of Aspirin Desensitization With Continuous Daily Aspirin Therapy in Aspirin-exacerbated Respiratory Disease.
    Walters KM; Waldram JD; Woessner KM; White AA
    Am J Rhinol Allergy; 2018 Jul; 32(4):280-286. PubMed ID: 29682983
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Objective and subjective sinonasal and pulmonary outcomes in aspirin desensitization therapy: A prospective cohort study.
    Cooper T; Greig SR; Zhang H; Seemann R; Wright ED; Vliagoftis H; Côté DWJ
    Auris Nasus Larynx; 2019 Aug; 46(4):526-532. PubMed ID: 30577986
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Aspirin or other nonsteroidal inflammatory agent exacerbated asthma.
    Ledford DK; Wenzel SE; Lockey RF
    J Allergy Clin Immunol Pract; 2014; 2(6):653-7. PubMed ID: 25439353
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Aspirin exacerbated respiratory disease: Current topics and trends.
    Rodríguez-Jiménez JC; Moreno-Paz FJ; Terán LM; Guaní-Guerra E
    Respir Med; 2018 Feb; 135():62-75. PubMed ID: 29414455
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Current complications and treatment of aspirin-exacerbated respiratory disease.
    Cook KA; Stevenson DD
    Expert Rev Respir Med; 2016 Dec; 10(12):1305-1316. PubMed ID: 27817219
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prevalence of aspirin-exacerbated respiratory disease among asthmatic patients: A meta-analysis of the literature.
    Rajan JP; Wineinger NE; Stevenson DD; White AA
    J Allergy Clin Immunol; 2015 Mar; 135(3):676-81.e1. PubMed ID: 25282015
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Performing Aspirin Desensitization in Aspirin-Exacerbated Respiratory Disease.
    Waldram JD; Simon RA
    Immunol Allergy Clin North Am; 2016 Nov; 36(4):693-703. PubMed ID: 27712764
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Early effects of aspirin desensitization treatment in asthmatic patients with aspirin-exacerbated respiratory disease.
    Berges-Gimeno MP; Simon RA; Stevenson DD
    Ann Allergy Asthma Immunol; 2003 Mar; 90(3):338-41. PubMed ID: 12669898
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A 1-Day, 90-Minute Aspirin Challenge and Desensitization Protocol in Aspirin-Exacerbated Respiratory Disease.
    DeGregorio GA; Singer J; Cahill KN; Laidlaw T
    J Allergy Clin Immunol Pract; 2019 Apr; 7(4):1174-1180. PubMed ID: 30391549
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Aspirin-exacerbated respiratory disease: characteristics and management strategies.
    Simon RA; Dazy KM; Waldram JD
    Expert Rev Clin Immunol; 2015; 11(7):805-17. PubMed ID: 25936612
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Aspirin-exacerbated respiratory disease: current diagnosis and treatment].
    He SC; Xu YT
    Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2020 Nov; 55(11):1091-1094. PubMed ID: 33210895
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Aspirin desensitization therapy in aspirin-exacerbated respiratory disease: a systematic review.
    Larivée N; Chin CJ
    Int Forum Allergy Rhinol; 2020 Apr; 10(4):450-464. PubMed ID: 31951112
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Upper airways in aspirin-exacerbated respiratory disease.
    Choi JH; Kim JH; Park HS
    Curr Opin Allergy Clin Immunol; 2015 Feb; 15(1):21-6. PubMed ID: 25546326
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Two patterns of changes in nasal nitric oxide after lysine aspirin nasal challenge in patients with aspirin-exacerbated respiratory disease.
    Tworek D; Kuprys-Lipinska I; Pietruszewska W; Kuna P
    Am J Rhinol Allergy; 2012; 26(6):428-32. PubMed ID: 23050514
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Long-term efficacy of aspirin desensitization in aspirin-exacerbated respiratory disease. Review of two clinical cases].
    Cambray-Gutiérrez JC; García-Ramírez UN; Del Rivero-Hernández LG; Lozano-Martínez SA; López-Pérez P; Chávez-García A
    Rev Alerg Mex; 2016; 63(2):207-12. PubMed ID: 27174764
    [TBL] [Abstract][Full Text] [Related]  

  • 20. AERD Associated Nasal Polyposis: Efficacy of Postoperative Antileukotriene Therapy in Comparison with Aspirin Desensitization. A Retrospective Study.
    San Nicoló M; Habermann N; Havel M
    Int Arch Allergy Immunol; 2020; 181(10):790-798. PubMed ID: 32777782
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.